UK markets closed

UnitedHealth Group Incorporated (UNH)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
495.35+1.49 (+0.30%)
At close: 04:00PM EDT
495.73 +0.38 (+0.08%)
After hours: 07:55PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 455.76B
Enterprise value 496.69B
Trailing P/E 30.24
Forward P/E 17.83
PEG ratio (5-yr expected) 1.40
Price/sales (ttm)1.22
Price/book (mrq)4.93
Enterprise value/revenue 1.31
Enterprise value/EBITDA 17.06

Trading information

Stock price history

Beta (5Y monthly) 0.56
52-week change 3-0.07%
S&P500 52-week change 322.36%
52-week high 3554.70
52-week low 3436.38
50-day moving average 3486.36
200-day moving average 3508.83

Share statistics

Avg vol (3-month) 34.49M
Avg vol (10-day) 36.05M
Shares outstanding 5920.08M
Implied shares outstanding 6921.93M
Float 8919.37M
% held by insiders 10.22%
% held by institutions 190.24%
Shares short (15 Apr 2024) 47.89M
Short ratio (15 Apr 2024) 41.77
Short % of float (15 Apr 2024) 40.86%
Short % of shares outstanding (15 Apr 2024) 40.86%
Shares short (prior month 15 Mar 2024) 47.29M

Dividends & splits

Forward annual dividend rate 47.52
Forward annual dividend yield 41.52%
Trailing annual dividend rate 37.52
Trailing annual dividend yield 31.52%
5-year average dividend yield 41.37
Payout ratio 445.91%
Dividend date 319 Mar 2024
Ex-dividend date 408 Mar 2024
Last split factor 22:1
Last split date 331 May 2005

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 4.05%
Operating margin (ttm)7.95%

Management effectiveness

Return on assets (ttm)7.09%
Return on equity (ttm)17.22%

Income statement

Revenue (ttm)379.49B
Revenue per share (ttm)411.26
Quarterly revenue growth (yoy)8.60%
Gross profit (ttm)N/A
EBITDA 35B
Net income avi to common (ttm)15.36B
Diluted EPS (ttm)16.40
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)32.71B
Total cash per share (mrq)35.48
Total debt (mrq)73.64B
Total debt/equity (mrq)75.98%
Current ratio (mrq)0.85
Book value per share (mrq)100.18

Cash flow statement

Operating cash flow (ttm)13.88B
Levered free cash flow (ttm)-4.55B